Health Care & Life Sciences » Pharmaceuticals | Biondvax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd.

Biondvax Pharmaceuticals Ltd. ADR
Stock Exchange NASDAQ Stock Market
EPS
$3.05
Market Cap
$38.04 M
Shares Outstanding
6.54 M
Public Float
6.18 M

Profile

Address
Jerusalem BioPark
Jerusalem JM 74036
Israel
Employees -
Website http://www.biondvax.com
Updated 07/08/2019
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases. It works on M-001, a synthetic peptide-based protein targeting both seasonal and pandemic strains of the influenza virus. The company was founded by Ron Babecoff and Rami Epstein on July 22, 2003 and is headquartered in Ness Ziona, Israel.

Financials

View All
Created with Highcharts 5.0.14Biondvax Pharmaceuticals Ltd. ADRNet Income. Fiscal year is January-December. All values ILS Thousands.8 0368 0367 7647 76410 19910 1999 1849 18434 55134 55124 40024 400201320142015201620172018010k20k30k40k

Avner Rotman
Chairman
Ronald Babecoff
President, Chief Executive Officer & Director